PRIMARY Ancillary Substudy

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 250 participants.

Also called NCT07103733

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose basic science
Phase
Not applicable
Enrolled
  • 250 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07103733
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Germany, United Kingdom (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07103733. Randomized; double masking; primary purpose basic science. Start 2023-10-16 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PRIMARY Ancillary Substudy
Condition
Mitral Valve Prolapse
Condition
Left Ventricular Fibrosis
Condition
Ventricular Arrhythmias
Intervention (Procedure)
Cardiac Magnetic Resonance Imaging
Intervention (Device)
ZioPatch Monitoring
Intervention (Procedure)
Myocardial Tissue Biopsy
Lead sponsor
Annetine Gelijns (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct07103733
Content hash
708640baef4100ffa419311a5bfc2595c5c4e050b442079e107b0bc0c452fff2